A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen

BACKGROUND: Colorectal cancer is a major public health issue worldwide. Interleukin-17 (IL-17) and Th17 (T-helper cell type 17)-related molecules are involved in tumor development and in resistance to bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody used in association wit...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Cancer
Главные авторы: Lereclus, Emilie, Tout, Mira, Girault, Alban, Baroukh, Nadine, Caulet, Morgane, Borg, Christophe, Bouché, Olivier, Ternant, David, Paintaud, Gilles, Lecomte, Thierry, Raoul, William
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5368920/
https://ncbi.nlm.nih.gov/pubmed/28347290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3210-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы